3-Bromo-1-(4-fluorophenyl)-1H-pyrazole-5-carboxylic acid, 95%, 250mg

(3-(n-(Tert-butyl)sulfamoyl)-4-methoxyphenyl)boronic acid, 98%, 5g

3-Bromo-2-methylbenzaldehyde, 95.0%, 10g

5,6,7,8-Tetrahydroquinoxaline>98.0%(GC)(T)25g

8-Methylquinolin-4(1H)-one, 95.0%, 1g

GC capillary column ROTI®Cap-1701, 50 m, 0.32 mm, 0.35 µm, 1 Piece(s)

1-(4-Fluoro-3-methylphenyl)ethanol, 97.0%, 1g

Magnesium chloride hexahydrate 99 +%. Ph. Eur, BP, FCC, food grade 500 gram

Syringe filters ROTILABO® Polytetrafluoroethylene (PTFE), 0,45 µm, 25 mm, Non-sterile, 100 Piece(s)

3-Chloro-2-(4-fluorophenyl)pyridine, 98%, 250mg

(2R)-3,4-Dihydro-2-phenyl-2H-pyrimido[2,1-b]benzothiazole, 250mg

TERT-BUTYL (5-HYDROXYNAPHTHALEN-1-YL)CARBAMATE, 95.0%, 100mg

ethyl 4,7-dichloro-8-methylquinoline-3-carboxylate, 95.0%, 1g